Structural silence on drugging assaults: How systemic denial enables serial predators across cultures
Original framing: “Gisèle Pelicot’s daughter launches awareness campaign for potential victims of drugging and sexual assault” — The Guardian - World
Sex workers, disabled survivors, and racial minorities face heightened risks of drugging assaults due to preexisting stigma—yet the campaign’s focus on 'respectable' victims excludes them. In the U.S., Black women are 1.5x more likely to report drugging assaults but face higher rates of police dismissal, while disabled survivors often lack access to medical testing. The campaign’s silence on these groups reflects how victimhood is racialized and ableist, with elite narratives centering white, able-bodied women.
The Pelicot campaign’s focus on 'coming forward' obscures how drugging assaults are enabled by a trifecta of **pharmaceutical complicity** (marketing GHB/GBL as 'party drugs'), **legal loopholes** (dismissing 'memory gaps' as evidence of consent), and **cultural stigma** (erasing marginalized survivors).
Indigenous frameworks like *whakapapa* and *ubuntu* reveal these assaults as **structural violations**—not individual tragedies—where healing requires dismantling colonial legal systems and corporate impunity. Historical parallels to 1980s Rohypnol crises show how pharmaceutical lobbying delays justice, while trickster readings expose the campaign’s performative allyship as a distraction from systemic change. Solutions must merge **restorative justice** (Indigenous models), **corporate accountability** (liability laws), and **decentralized data** (AI/blockchain) to shift from victim blaming to predator dismantling.